Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)
Main Authors: | Marigdalia K. Ramirez-Fort, Casey K. Gilman, Jacob S. Alexander, Barbara Meier-Schiesser, Arjan Gower, Mojtaba Olyaie, Neel Vaidya, Kiarash Vahidi, Yuxin Li, Christopher S. Lange, Migdalia Fort, Corinne Deurdulian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1304718/full |
Similar Items
-
SkIndia Quiz 25: A solitary nodule on the right buttock
by: Reza Yaghoobi, et al.
Published: (2016-01-01) -
Bacteriophages as Solid Tumor Theragnostic Agents
by: Srivani Veeranarayanan, et al.
Published: (2021-12-01) -
Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA
by: Hans-S. Jans, et al.
Published: (2022-08-01) -
Polymeric Theragnostic Nanoplatforms for Bone Tissue Engineering
by: Kaushita Banerjee, et al.
Published: (2023-07-01) -
Molecular Imaging and Theragnostics of Thyroid Cancers
by: Luca Giovanella, et al.
Published: (2022-03-01)